MannKind | MNKD - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q3 Sep/2026 -0.01 0.01 0.07 Nov/05
FY2026Q2 Jun/2026 -0.01 -0.01 0.05 Aug/05
FY2026Q1 Mar/2026 -0.02 -0.01 0.07 May/06
FY2025Q4 Dec/2025 0.01 0.01 0.08 Feb/26
FY2025Q3 Sep/2025 0.07 0.02 0.06 Nov/05




Eps Cambiamento Data
Adma Biologics USD 0.16 0.03 2026-06
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
Eli Lilly USD 7.48 0.9 2026-09
Halozyme Therapeutics USD 2.39 0.11 2026-09
Insmed USD -0.46 0.4 2026-09
Karyopharm Therapeutics USD -1.02 1.2 2026-03
MacroGenics USD 0.31 0.89 2026-06
MannKind USD -0.01 0 2026-09
Merck USD 2.49 2.62 2026-09
Minerva Neurosciences USD -0.56 3.53 2024-12
Novavax USD 0.13 0.59 2025-12
Novo Nordisk DKK 0.96 9.95 2026-06
Pfizer USD 0.87 0.1 2026-09
Sanofi EUR 3.55 1.46 2026-09
Xencor USD 0.5 0.79 2026-09